Fehnel Sheri E, Forsyth Barbara H, DiBenedetti Dana B, Danchenko Natalya, François Clément, Brevig Thomas
1Patient-Reported Outcomes,RTI Health Solutions,Research Triangle Park,North Carolina,USA.
2Health Economics and HTA Management,Lundbeck SAS,Issy-les-Moulineaux,France.
CNS Spectr. 2016 Feb;21(1):43-52. doi: 10.1017/S1092852913000643. Epub 2013 Sep 25.
To identify and explore concepts important to patients with cognitive symptoms of major depressive disorder (MDD) and adapt an existing patient-reported outcome (PRO) measure to assess these symptoms.
Four focus groups were conducted with MDD patients (n = 33) to elicit relevant concepts and determine whether one of several PRO scales could be used to assess cognitive symptoms of depression. Following selection and minor modification of the Perceived Deficits Questionnaire (PDQ), cognitive debriefing interviews were conducted with additional patients (n = 17) to further refine and adapt this measure for use in MDD. Minor revisions based on patient input yielded the PDQ for Depression (PDQ-D).
Focus group participants reported a variety of cognitive symptoms that were classified into 7 general categories: lack of focus and clear thought, memory problems, difficulty with lexical access, difficulty with divided attention, difficulty with decision making, difficulty thinking quickly, and difficulty learning new things. Limitations in work productivity were the most commonly reported impacts of cognitive symptoms. While suggesting a few modifications, focus group participants reacted positively to the PDQ based on the breadth, specificity, and relevance of the items. Cognitive debriefing participants indicated that the modified PDQ items were generally easy to understand and relevant to their experiences with MDD.
Because cognitive symptoms are burdensome to patients with MDD, their assessment is important to optimize treatment outcomes. The PDQ-D has the potential to supplement existing assessment methods, providing unique information important for both comprehensive evaluation of individuals with MDD and evaluation of new treatments.
识别并探索对重度抑郁症(MDD)认知症状患者重要的概念,并调整现有的患者报告结局(PRO)测量方法以评估这些症状。
对MDD患者(n = 33)进行了四个焦点小组访谈,以引出相关概念,并确定几种PRO量表中的一种是否可用于评估抑郁症的认知症状。在选择并对感知缺陷问卷(PDQ)进行轻微修改后,对另外17名患者进行了认知反馈访谈,以进一步完善和调整该测量方法,使其适用于MDD。根据患者的意见进行的小修改产生了抑郁症感知缺陷问卷(PDQ-D)。
焦点小组参与者报告了多种认知症状,这些症状分为7大类:注意力不集中和思维不清晰、记忆问题、词汇提取困难、注意力分散困难、决策困难、思维速度慢以及学习新知识困难。工作效率受限是认知症状最常报告的影响。虽然提出了一些修改建议,但焦点小组参与者基于项目的广度、特异性和相关性对PDQ反应积极。认知反馈参与者表示,修改后的PDQ项目通常易于理解,且与他们的MDD经历相关。
由于认知症状对MDD患者造成负担,对其进行评估对于优化治疗效果很重要。PDQ-D有潜力补充现有的评估方法,为全面评估MDD患者和评估新治疗方法提供重要的独特信息。